1998
Haemodynamic stability and ketamine-alfentanil anaesthetic induction
Katz R, Levy A, Slepian B, Sobel B, Lagasse R. Haemodynamic stability and ketamine-alfentanil anaesthetic induction. British Journal Of Anaesthesia 1998, 81: 702-706. PMID: 10215313, DOI: 10.1093/bja/81.5.702.Peer-Reviewed Original ResearchConceptsArterial pressureHeart rateHaemodynamic instabilityDose of alfentanilPostoperative patient complaintsInduction of anesthesiaAdministration of ketamineAlfentanil 10Postoperative dysphoriaASA IHaemodynamic stabilityTracheal intubationAnesthetic inductionPatient complaintsGroup 1Group 3KetamineObtundationAlfentanilPatientsMicrogramsGroupDysphoriaInductionIntubation
1995
Original Articles
Yu H, Diamandis E. Original Articles. Journal Of Urology 1995, 153: 1004-1008.. DOI: 10.1097/00005392-199503000-00026.Peer-Reviewed Original ResearchSerum prostate-specific antigenProstate-specific antigenPSA levelsDetectable serum prostate specific antigenDistribution of PSAHigher serum prostate-specific antigenHealthy female blood donorsMeasurable prostate-specific antigenPostoperative prostate-specific antigenPreoperative prostate-specific antigenYear of surgeryEvidence of relapseFemale blood donorsAge 50 yearsProstate cancer patientsHospitalized womenPatients 50Recurrent tumorsHistological gradeCancer patientsRadical prostatectomyBlood donorsSpecific antigenFemale serumMicrograms
1991
Short report: plasma aluminium concentration and 24‐hour urinary aluminium excretion before, during and after treatment with sucralfate
MISTRY P, VARGHESE Z, POUNDER RE. Short report: plasma aluminium concentration and 24‐hour urinary aluminium excretion before, during and after treatment with sucralfate. Alimentary Pharmacology & Therapeutics 1991, 5: 549-553. PMID: 1793786, DOI: 10.1111/j.1365-2036.1991.tb00524.x.Peer-Reviewed Original ResearchConceptsUrinary aluminium excretionPlasma aluminum concentrationAluminium excretionNormal renal functionCessation of treatmentWeeks of treatmentSucralfate q.Renal functionDyspeptic patientsUrinary excretionStandard treatmentPretreatment levelsSucralfateTissue accumulationExcretionSignificant riseWeeksTreatmentSignificant increaseMicrogramsPatientsPsychophysical Studies of the Itch Sensation and Itchy Skin (“Alloknesis”) Produced by Intracutaneous Injection of Histamine
Simone D, Alreja M, Lamotte R. Psychophysical Studies of the Itch Sensation and Itchy Skin (“Alloknesis”) Produced by Intracutaneous Injection of Histamine. Somatosensory & Motor Research 1991, 8: 271-279. PMID: 1767623, DOI: 10.3109/08990229109144750.Peer-Reviewed Original ResearchConceptsDuration of itchSubcutaneous injectionIntracutaneous injectionItchy skinArea of alloknesisSensation of itchMicrograms of histamineSkin temperatureItch sensationLocal anesthesiaAlloknesisMean latencyInjection siteMean maximum areaItchHuman volunteersHistamineVolar forearmDose-response functionInjectionNeural mechanismsSkinDoseDurationMicrograms
1987
The Magnitude and Duration of Itch Produced by Intracutaneous Injections of Histamine
Simone D, Ngeow J, Whitehouse J, Becerra-Cabal L, Putterman G, Lamotte R. The Magnitude and Duration of Itch Produced by Intracutaneous Injections of Histamine. Somatosensory & Motor Research 1987, 5: 81-92. PMID: 3423533, DOI: 10.3109/07367228709144620.Peer-Reviewed Original ResearchConceptsDuration of itchArea of flareIntracutaneous injectionDose-dependent fashionHistamine doseMicrograms of histaminePeripheral neural mechanismsDose-dependent mannerIntracutaneous histamineItch magnitudeItch sensationLow doseItchHistamineVolar forearmDoseNeurophysiological studiesLonger durationMicrogramsMultiple injectionsInjectionNeural mechanismsDurationWeeksSubjects
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply